Dupilumab is effective in type 2‐high asthma patients receiving high‐dose inhaled corticosteroids at baseline-Reference-Cited by-同舟云学术

Dupilumab is effective in type 2‐high asthma patients receiving high‐dose inhaled corticosteroids at baseline

Published:2020-10-21 Issue:1 Volume:76 Page:269-280
ISSN:0105-4538
Container-title:Allergy
language:en
Short-container-title:Allergy

Author:

Bourdin Arnaud¹^ORCID,Papi Alberto A.²,Corren Jonathan³,Virchow J. Christian⁴^ORCID,Rice Megan S.⁵,Deniz Yamo⁶,Djandji Michel⁵,Rowe Paul⁷,Pavord Ian D.⁸

Affiliation:

1. Department of Respiratory Diseases INSERM U1046 University of Montpellier Montpellier France

2. Università degli Studi di Ferrara Ferrara Italy

3. David Geffen School of Medicine at UCLA Los Angeles CA USA

4. Universitätsmedizin Rostock Rostock Germany

5. Sanofi Cambridge MA USA

6. Regeneron Pharmaceuticals, Inc. Tarrytown NY USA

7. Sanofi Bridgewater NJ USA

8. University of Oxford Oxford UK

Funder

Regeneron Pharmaceuticals

Sanofi España

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/all.14611

Reference42 articles.

1. Substitution of Beclomethasone Aerosol for Oral Prednisolone in the Treatment of Chronic Asthma

2. Immunosuppression by Glucocorticoids: Inhibition of NF-κB Activity Through Induction of IκB Synthesis

3. Inflammation in asthma: The cornerstone of the disease and target of therapy

4. Refractory asthma: mechanisms, targets, and therapy

5. Inhaled Corticosteroid Therapy in Adult Asthma. Time for a New Therapeutic Dose Terminology

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of Dupilumab in Pediatric Patients: A Review;Current Pediatrics Reports;2024-06-20

2. Effects of total alkaloids from (L.) R. Br. on ovalbumin-induced asthma mice;Journal of Ethnopharmacology;2024-01

3. Real-World Characteristics of Patients with Severe Asthma prior to Starting Dupilumab: The ProVENT Study;Respiration;2023-12-12

4. Cost-effectiveness analysis of dupilumab versus omalizumab, mepolizumab, and benralizumab added to the standard of care in adults with severe asthma in Colombia;Expert Review of Pharmacoeconomics & Outcomes Research;2023-11-23

5. Climate change and the epithelial barrier theory in allergic diseases: A One Health approach to a green environment;Allergy;2023-09-07